Literature DB >> 32361556

Should hearing targeted screening for congenital cytomegalovirus infection Be implemented?

Travis Haller1, Angela Shoup2, Albert H Park3.   

Abstract

Since 2013, after Utah became the first state to implement hearing targeted early CMV screening, a national debate has been percolating about whether this approach should be introduced nationally. Currently Utah, Iowa, Connecticut, and New York have passed legislation mandating early CMV screening, and over 100 birth hospitals across the United States have voluntarily implemented early CMV screening programs as part of their standard of care. We reviewed the evidence related to this approach and used the Wilson and Jungner (1968) criteria to evaluate this method of screening. Based on these criteria, there is substantial rationale and evidence to support a hearing targeted approach to screen for congenital CMV. Given this evidence, we currently recommend that infants who fail newborn hearing screen should undergo CMV screening.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytomegalovirus; Sensorineural hearing loss; Universal newborn hearing screening

Mesh:

Year:  2020        PMID: 32361556      PMCID: PMC7293539          DOI: 10.1016/j.ijporl.2020.110055

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  39 in total

1.  Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus.

Authors:  A J Dahle; K B Fowler; J D Wright; S B Boppana; W J Britt; R F Pass
Journal:  J Am Acad Audiol       Date:  2000-05       Impact factor: 1.664

2.  Impact of expanded newborn screening--United States, 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-09-19       Impact factor: 17.586

3.  Newborn screening of congenital cytomegalovirus infection using saliva can be influenced by breast feeding.

Authors:  Shin Koyano; Naoki Inoue; Tsunehisa Nagamori; Hiroyuki Moriuchi; Hiroshi Azuma
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2012-08-08       Impact factor: 5.747

Review 4.  Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?

Authors:  Michael J Cannon; Paul D Griffiths; Van Aston; William D Rawlinson
Journal:  Rev Med Virol       Date:  2014-04-24       Impact factor: 6.989

5.  Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection.

Authors:  Suresh B Boppana; Shannon A Ross; Zdenek Novak; Masako Shimamura; Robert W Tolan; April L Palmer; Amina Ahmed; Marian G Michaels; Pablo J Sánchez; David I Bernstein; William J Britt; Karen B Fowler
Journal:  JAMA       Date:  2010-04-14       Impact factor: 56.272

6.  Cost-benefit analysis of targeted hearing directed early testing for congenital cytomegalovirus infection.

Authors:  Anna Bergevin; Cathleen D Zick; Stephanie Browning McVicar; Albert H Park
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2015-09-25       Impact factor: 1.675

7.  Economic cost of congenital CMV in the UK.

Authors:  Jenny Retzler; Nick Hex; Chris Bartlett; Anne Webb; Sharon Wood; Caroline Star; Paul Griffiths; Christine E Jones
Journal:  Arch Dis Child       Date:  2018-11-24       Impact factor: 3.791

8.  Valganciclovir for symptomatic congenital cytomegalovirus disease.

Authors:  David W Kimberlin; Penelope M Jester; Pablo J Sánchez; Amina Ahmed; Ravit Arav-Boger; Marian G Michaels; Negar Ashouri; Janet A Englund; Benjamin Estrada; Richard F Jacobs; José R Romero; Sunil K Sood; M Suzanne Whitworth; Mark J Abzug; Mary T Caserta; Sandra Fowler; Jorge Lujan-Zilbermann; Gregory A Storch; Roberta L DeBiasi; Jin-Young Han; April Palmer; Leonard B Weiner; Joseph A Bocchini; Penelope H Dennehy; Adam Finn; Paul D Griffiths; Suzanne Luck; Kathleen Gutierrez; Natasha Halasa; James Homans; Andi L Shane; Michael Sharland; Kari Simonsen; John A Vanchiere; Charles R Woods; Diane L Sabo; Inmaculada Aban; Huichien Kuo; Scott H James; Mark N Prichard; Jill Griffin; Dusty Giles; Edward P Acosta; Richard J Whitley
Journal:  N Engl J Med       Date:  2015-03-05       Impact factor: 91.245

9.  Outcomes From a Hearing-Targeted Cytomegalovirus Screening Program.

Authors:  Marissa L Diener; Cathleen D Zick; Stephanie Browning McVicar; Jill Boettger; Albert H Park
Journal:  Pediatrics       Date:  2017-02       Impact factor: 7.124

10.  Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection.

Authors:  Soren Gantt; Francois Dionne; Fred K Kozak; Oran Goshen; David M Goldfarb; Albert H Park; Suresh B Boppana; Karen Fowler
Journal:  JAMA Pediatr       Date:  2016-12-01       Impact factor: 16.193

View more
  2 in total

1.  Universal newborn hearing screening in the Italian Region of Sicily in 2018.

Authors:  Salvatore Ferlito; Antonino Maniaci; Salvatore Cocuzza; Ignazio La Mantia; Paola Di Mauro; Graziella Poli; Luigi Maiolino; Salvatore Coco; Federico Merlino; Marina Maltese; Margherita Ragliani; Michele Russo; Alessandro Gulino; Carmen Azieli; Francesco Martines; Francesco Galletti; Luciano Bubbico
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-08       Impact factor: 2.124

2.  Congenital Cytomegalovirus Knowledge, Practices, and Beliefs Among Primary Care Physicians and Newborn Hospitalists.

Authors:  Megan H Pesch; Kathleen M Muldoon
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.